Paper Details 
Original Abstract of the Article :
BACKGROUND: Hypothyroid crisis, or myxoedema coma, is a rare condition with high mortality and must be treated promptly. Even though it may be unfavourable, most guidelines only focus on intravenous drug administration due to lack of data on oral treatment. METHODS/RESULTS: The course of oral treat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523370/

データ提供:米国国立医学図書館(NLM)

Navigating the Shifting Sands of Hypothyroid Crisis

[Hypothyroid crisis], or myxoedema coma, is a rare but serious condition that can be life-threatening. It's like a sudden storm in a usually calm desert. Doctors have long relied on intravenous medications to treat this condition, but this study presents a case for oral treatment as a viable alternative. The researchers share their experience with two patients successfully treated with oral levothyroxine and liothyronine, highlighting the potential for a safer and more accessible approach.

Oral Treatment: A New Oasis in the Desert of Hypothyroid Crisis

This study provides valuable insights into the use of oral treatment for hypothyroid crisis. The successful outcomes observed in these two patients suggest that oral administration may be a safe and effective alternative to intravenous therapy. This finding could be particularly beneficial in situations where intravenous medications are not readily available or pose certain risks.

Finding the Right Path in a Medical Desert

This study underscores the importance of exploring and adapting our medical practices to meet the unique needs of patients. The researchers' experience with oral treatment for hypothyroid crisis reminds us that innovative approaches can often lead to better outcomes.

Dr.Camel's Conclusion

This case study provides a valuable perspective on the treatment of hypothyroid crisis, suggesting that oral medication may offer a safe and effective alternative to intravenous therapy. This opens up new possibilities for patient care, especially in resource-limited settings.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-04-27
Further Info :

Pubmed ID

34671573

DOI: Digital Object Identifier

PMC8523370

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.